An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients.

about

Efficacy and safety of pathogen-reduced platelet concentrates in children with cancer: a retrospective cohort study.Platelet Transfusion Thresholds Among Children Admitted to a Pediatric Intensive Care Unit.Guidelines on transfusion for fetuses, neonates and older children.

P2860

Q33430917-C087098B-3363-4182-B3B0-26395BF4E49F Q47241256-80FC8B8F-FB10-4130-A3A1-50FABB718BB7 Q53674609-1201929C-3DEE-41E8-A104-DE2A9E2B8E7B

P2860

An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients.

Item

http://www.wikidata.org/entity/Q38207717

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

An epidemiologic cohort study ...... f pediatric oncology patients.

@en

type

Item

label

An epidemiologic cohort study ...... f pediatric oncology patients.

@en

prefLabel

An epidemiologic cohort study ...... f pediatric oncology patients.

@en

P1476

An epidemiologic cohort study ...... f pediatric oncology patients.

@en

P2093

Carol Portwine

http://www.w3.org/2001/XMLSchema#string

Lani Lieberman

http://www.w3.org/2001/XMLSchema#string

Nancy M Heddle

http://www.w3.org/2001/XMLSchema#string

Rebecca L Barty

http://www.w3.org/2001/XMLSchema#string

Yang Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.

Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction.

Interventions for anemia in pediatric cancer patients.

Guidelines for assessing appropriateness of pediatric transfusion.

Pitfalls of adverse event reporting in paediatric cardiac intensive care.

Platelets, frozen plasma, and cryoprecipitate: what is the clinical evidence for their use in the neonatal intensive care unit?

Variations in transfusion practice in neonatal intensive care.

Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction.

P304

2736-2744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.12677

http://www.w3.org/2001/XMLSchema#string

P433

10 Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24773382

http://www.w3.org/2001/XMLSchema#string

An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients.

about

P2860

P2860

An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698